Compare iShares MSCI Hong Kong ETF (EWH) vs Oruka Therapeutics Inc. Common Stock (ORKA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares MSCI Hong Kong ETF vs Oruka Therapeutics Inc. Common Stock — how do they compare? iShares MSCI Hong Kong ETF trades at $21.92 (market cap $1.21B), while Oruka Therapeutics Inc. Common Stock trades at $76.8 (market cap $5.08B). The key difference: Oruka Therapeutics Inc. Common Stock is far larger — about 4.2× iShares MSCI Hong Kong ETF's market cap, and Oruka Therapeutics Inc. Common Stock is trading nearer its 52-week high, iShares MSCI Hong Kong ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares MSCI Hong Kong ETF for 63 Days and Oruka Therapeutics Inc. Common Stock for 0 Days on average.
| EWH | ORKA | |
|---|---|---|
Market Cap | $1.21B | $5.08B |
Volume | 9,334,618 | 685,276 |
Sector | Broad Market / Factor | Health |
52-Week High | $24.55 | $113.08 |
52-Week Low | $20.92 | $26.19 |
Typical Hold Time | 63 Days | 0 Days |
Enterprise Value | — | $4.21B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EWH (iShares MSCI Hong Kong ETF) trades at $22.35, up 1.78% today, but faces bearish technical signals with moving averages indicating selling pressure. The ETF tracks Hong Kong stocks, which have experienced significant volatility amid US-China tensions and Federal Reserve policy concerns. Recent news highlights the Hang Seng Index's 11% decline from yearly highs, reflecting investor caution toward Chinese markets.
The outlook remains cautious due to geopolitical risks and Hong Kong's economic challenges. While technical oscillators show neutral momentum, institutional selling (Empowered Funds reduced holdings by 70% in Q3 2026) signals bearish sentiment. Key risks include US-China relations and Fed policy, but potential rebounds hinge on regional stability and tech sector recovery.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About iShares MSCI Hong Kong ETF
EWH tracks the MSCI Hong Kong 25/50 Index, providing broad exposure to large and mid-cap companies listed in Hong Kong. It focuses on the established pillars of the local economy, with heavy weightings in financials, real estate, and utilities, serving as a single-country diversification tool.
Read more on EWH →About Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →
